Filing Details

Accession Number:
0001209191-20-049920
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-10 08:49:22
Reporting Period:
2020-09-08
Accepted Time:
2020-09-10 08:49:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1503802 Karyopharm Therapeutics Inc. KPTI Pharmaceutical Preparations (2834) 263931704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1603510 Brett Christopher Primiano C/O Karyopharm Therapeutics Inc.
85 Wells Avenue
Newton MA 02459
Evp, Cbo, Gc & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-08 10,054 $6.54 14,703 No 4 M Direct
Common Stock Disposition 2020-09-08 10,054 $14.98 4,649 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2020-09-08 10,054 $0.00 10,054 $6.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-01-14 No 4 M Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 15, 2017, and the remaining 75% vested in 36 equal monthly installments thereafter.